The plasma rich in growth factors, in regenerative medicine treatments, has become one of the greatest advances in this field. It is a versatile technology, applicable in different medical fields, such as dentistry, traumatology, ophthalmology and even aesthetic medicine. Now thanks to IVI Regenerates, becomes a novel technique for reproductive medicine.
“Plasma rich in growth factors (PRGF) has a positive effect in the very short term, in terms of efficacy, safety and minimal invasiveness for the patient. Based on the studies we have conducted, we believe that very promising results can be achieved by using PRGF on the reproductive organs. This represents a great advance in terms of possibilities of success in assisted reproduction for patients with difficult prognoses ”, explains Dr. Antonio Requena, IVI’s medical director.
IVI Regenera: plasma rich in growth factors for patients with difficult reproductive prognosis
For all this is born IVI Regenerates, a clear commitment by IVI to incorporate the use of PRGF, which is a viable alternative for patients with difficult reproductive prognosis. It is a pioneering technology that offers encouraging results in the treatment of refractory endometrium, premature ovarian failure and low ovarian reserve.
“This technology is based on the principles of regenerative medicine, which aims to restore ‘the biological environment.’ Thus, the regeneration processes of the organism itself are imitated and accelerated. Through this treatment, growth factors are obtained from the patient’s own blood plasma. Later, they are applied to the endometrium of the same or, in a later phase, to their ovaries, to regenerate them “explains Dr. Requena.
It is an autologous process, using the patient’s own biological material, thus avoiding possible compatibility problems. A) Yes, IVI Regenerates It is a painless, fast, safe technique with great guarantees of success, assuming a new hope for patients.
IVI Regenerates for the endometrium
As has been said, PRGF can be applied to the endometrium in cases where this organ does not reach the necessary thickness to host the pregnancy. This phenomenon is known in reproductive medicine as refractory endometrium.
“We know that optimal endometrial conditions are necessary for the embryo to implant. Therefore, the state of the endometrium can affect the outcome of an in vitro fertilization (IVF) cycle ”adds Dr. Requena.
Through IVI Regenerates Endo we will be able to regenerate the endometrium, thanks to the obtaining of growth factors through the patient’s own blood plasma. Developing this process makes it possible for the endometrium to reach the necessary thickness to favor the implantation of the embryo.
IVI Regenera for the ovary, coming soon
In the same way, the use of PRGF also translates into great results in its application on the ovary. In this sense, it is a very useful alternative for patients with premature ovarian failure or low ovarian reserve.
“The common denominator of patients diagnosed with ovarian failure is that they cannot ovulate, given the limited number of primordial follicles they present. Therefore, its treatment is considered a challenge in the context of fertility treatment. Something similar happens with women with low ovarian reserve, where the lack of follicles that can respond to ovarian stimulation results in low oocyte performance and a high rate of cancellation after assisted reproduction treatment “, concludes Dr. Requena.
IVI Regenerates Ovary It consists of the injection of plasma enriched with growth factors into the ovary. Thanks to this, patients have a new effective alternative in assisted reproduction processes. IVI Regenera Ovario is a second phase, after IVI Regenera Endometrio. This makes it possible to restore and repair the physiological processes that affect follicular recruitment, in turn helping to recover ovarian function.
